High potassium, or hyperkalemia, occurs when blood potassium levels exceed 5.0 mmol/L. This condition disrupts nerve and muscle function, especially in the heart, and can lead to life-threatening arrhythmias if untreated.
Potassium is essential for nerve signaling, muscle contraction, and fluid balance. The kidneys regulate its levels by excreting excess through urine. When this system fails, potassium accumulates in the bloodstream. Normal ranges are 3.5-5.0 mmol/L; levels above 6.0 mmol/L require urgent treatment.
Hyperkalemia often develops slowly and may show no early symptoms. As levels rise, signs include fatigue, numbness, muscle cramps, and nausea. Severe cases cause palpitations, chest pain, or sudden collapse due to cardiac arrest. A 2021 study in the Journal of the American Society of Nephrology found that patients with potassium above 6.5 mmol/L had a 3.2-fold higher risk of cardiovascular death within 30 days.
Potassium influences electrical activity in cells. When levels rise, cell membranes become less stable, making nerves and muscles harder to control. The heart relies on precise ion balances to maintain rhythm. Excess potassium depolarizes cardiac cells, increasing the chance of ventricular fibrillation or asystole.
Electrocardiogram (ECG) changes reflect this instability. Early signs include peaked T waves, widened QRS complexes, and eventually a sine wave pattern before cardiac standstill. These patterns appear in about 70% of severe cases, according to the National Kidney Foundation.
A 62-year-old woman with stage 3 chronic kidney disease presented with generalized weakness and irregular pulse. Her lab showed potassium at 6.8 mmol/L. An ECG revealed tall, narrow T waves and a prolonged PR interval. After intravenous calcium gluconate and insulin-glucose infusion, her potassium dropped to 5.1 mmol/L within 45 minutes.
Most cases stem from reduced kidney function, medication side effects, or sudden cellular breakdown. The kidneys filter out about 90% of daily potassium intake. When glomerular filtration rate (GFR) drops below 30 mL/min/1.73m², potassium retention becomes likely.
Medications like ACE inhibitors, ARBs, spironolactone, and NSAIDs interfere with aldosterone action or renal perfusion, reducing potassium excretion. A 2020 review in Pharmacotherapy reported that 12% of patients on ACE inhibitors developed hyperkalemia within six months.
| Category | Examples | Prevalence in Hyperkalemia Cases |
|---|---|---|
| Kidney dysfunction | CKD stage 3+, acute injury | 45% |
| Medications | ACE inhibitors, potassium supplements | 28% |
| Cell damage | Severe trauma, rhabdomyolysis | 12% |
| Endocrine disorders | Addison's disease, hypoaldosteronism | 8% |
Less common triggers include tumor lysis syndrome, Addison's disease, and pseudohyperkalemia - a lab artifact caused by hemolysis during blood draw. Pseudohyperkalemia falsely elevates readings but doesn't affect physiology. Confirming true hyperkalemia requires repeat testing with proper sample handling.
Do not assume mild elevation is harmless. Even moderate increases (5.1-5.5 mmol/L) correlate with higher mortality in older adults, per a 2019 cohort study in Annals of Internal Medicine.
If you have diabetes, heart failure, or take medications like losartan or furosemide, monitor potassium regularly. Symptoms like tingling, muscle weakness, or palpitations warrant immediate evaluation. Emergency treatment includes IV calcium to stabilize the heart, insulin and glucose to shift potassium into cells, and sodium bicarbonate in select cases.
When potassium rises rapidly, especially with symptoms, seek emergency care. Delaying treatment increases the risk of sudden cardiac death. A single episode of severe hyperkalemia can trigger irreversible cardiac events.